Immuneering Corp. (IMRX)
5.02
+0.16
(+3.29%)
USD |
NASDAQ |
Mar 20, 16:00
5.05
+0.03
(+0.60%)
After-Hours: 20:00
Immuneering Market Cap : 324.56M for March 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vanda Pharmaceuticals, Inc. | 420.85M |
| Verastem, Inc. | 485.73M |
| Phathom Pharmaceuticals, Inc. | 883.33M |
| Tango Therapeutics, Inc. | 2.771B |
| X4 Pharmaceuticals, Inc. | 389.14M |
Market Cap Related Metrics
| Price to Book Value | 1.486 |
| Price | 5.02 |
| Earnings Yield | -27.51% |